For purchasing or obtaining a quotation, please visit the Distributor page
to find your local distributor.
to find your local distributor.
HOME > Product search results
Searched by
MHC Allele - A*03:01
Product
[-] MHC tetramer（57）
>Class I（57）
Refine your search
[+]Animal species
[+]Category
[+]Conjugate
[+]MHC Allele
[+]Research area
[+]Tools
[+]Brands
[+]Availability (in Japan)
MHC tetramer（57）
1
| Clip | Code No. | Product | Data | |||
|---|---|---|---|---|---|---|
| Data
Sheet |
Category | Conjugate | MHC Allele | Size | Availability | |
| Sequence | Location (aa) | Storage
temp. |
||||
|
|
||||||
|
TS-M100-2 |
HLA-A*03:01 CMV IE1 184-192 Tetramer-KLGGALQAK-APC |
|
|||
|
virus | APC | A*03:01 | 50 tests |
0 (Contact us) |
|
| KLGGALQAK | 184-192 | ４°C | ||||
|
|
TS-M033-1 |
HLA-A*03:01 EBV EBNA3A 603-611 Tetramer-RLRAEAQVK-PE |
|
|||
|
|
virus | PE | A*03:01 | 50 tests |
0 (Contact us) |
|
| RLRAEAQVK | 603-611 | ４°C | ||||
|
|
TS-M124-2 |
HLA-A*03:01 EBV BRLF1 Tetramer-RVRAYTYSK-APC |
|
|||
|
|
virus | APC | A*03:01 | 50 tests |
0 (Contact us) |
|
| RVRAYTYSK | 148-156 | ４°C | ||||
|
|
TS-M124-1 |
HLA-A*03:01 EBV BRLF1 Tetramer-RVRAYTYSK-PE |
|
|||
|
|
virus | PE | A*03:01 | 50 tests |
0 (Contact us) |
|
| RVRAYTYSK | 148-156 | ４°C | ||||
|
|
TS-M100-1 |
HLA-A*03:01 CMV IE1 184-192 Tetramer-KLGGALQAK-PE |
|
|||
|
|
virus | PE | A*03:01 | 50 tests | 1-9 | |
| KLGGALQAK | 184-192 | ４°C | ||||
|
|
TS-M033-2 |
HLA-A*03:01 EBV EBNA3A 603-611 Tetramer-RLRAEAQVK-APC |
|
|||
|
|
virus | APC | A*03:01 | 50 tests |
0 (Contact us) |
|
| RLRAEAQVK | 603-611 | ４°C | ||||
|
|
TS-7306-2R |
QuickSwitch™ Quant HLA-A*03:01 Tetramer Kit-APC (2-8℃) |
|
|||
|
|
Others | APC | A*03:01 | 1 kit |
0 (Contact us) |
|
| - | ４°C | |||||
|
|
TS-7306-4F |
QuickSwitch™ Quant HLA-A*03:01 Tetramer Kit-BV421 (frozen) |
|
|||
| Others | BV421 | A*03:01 | 1 kit |
0 (Contact us) |
||
| Custom | －２０°C | |||||
|
|
TS-7306-1F |
QuickSwitch™ Quant HLA-A*03:01 Tetramer Kit-PE (frozen) |
|
|||
| Others | PE | A*03:01 | 1 kit | 1-9 | ||
| Custom | －２０°C | |||||
|
|
TC-0137-1 |
HLA-A*03:01 HPV E6 Tetramer-KLCLRFLSK-PE |
|
|||
|
|
virus | PE | A*03:01 | 50 tests |
0 (Contact us) |
|
| KLCLRFLSK | 64-72 | ４°C | ||||
|
|
TS-7306-2F |
QuickSwitch™ Quant HLA-A*03:01 Tetramer Kit-APC (frozen) |
|
|||
| Others | APC | A*03:01 | 1 kit |
0 (Contact us) |
||
| Custom | －２０°C | |||||
|
|
TC-0108-1 |
HLA-A*03:01 Survivin 18-27 (modK) Tetramer-RISTFKNWPK-PE |
|
|||
|
|
cancer | PE | A*03:01 | 50 tests |
0 (Contact us) |
|
| RISTFKNWPK | ４°C | |||||
|
|
TS-7306-1R |
QuickSwitch™ Quant HLA-A*03:01 Tetramer Kit-PE (2-8℃) |
|
|||
|
|
Others | PE | A*03:01 | 1 kit | 1-9 | |
| - | ４°C | |||||
|
|
TS-7306-4R |
QuickSwitch™ Quant HLA-A*03:01 Tetramer Kit-BV421 (2-8℃) |
|
|||
|
|
Others | BV421 | A*03:01 | 1 kit |
0 (Contact us) |
|
| - | ４°C | |||||
|
|
TC-0108-4 |
HLA-A*03:01 Survivin 18-27 (modK) Tetramer-RISTFKNWPK-BV421 |
|
|||
|
|
cancer | BV421 | A*03:01 | 50 tests |
0 (Contact us) |
|
| RISTFKNWPK | ４°C | |||||
|
|
TC-0137-2 |
HLA-A*03:01 HPV E6 Tetramer-KLCLRFLSK-APC |
|
|||
|
|
virus | APC | A*03:01 | 50 tests |
0 (Contact us) |
|
| KLCLRFLSK | 64-72 | ４°C | ||||
|
|
TC-0103-1 |
HLA-A*03:01 Influenza NP Tetramer-ILRGSVAHK-PE |
|
|||
|
|
virus | PE | A*03:01 | 50 tests |
0 (Contact us) |
|
| ILRGSVAHK | ４°C | |||||
|
|
TC-0109-2 |
HLA-A*03:01 HIV p17 gag Tetramer-RLRPGGKKK-APC |
|
|||
|
|
virus | APC | A*03:01 | 50 tests |
0 (Contact us) |
|
| RLRPGGKKK | ４°C | |||||
|
|
TC-0166-1 |
HLA-A*03:01 gp100 Tetramer-ALLAVGATK-PE |
|
|||
|
|
cancer | PE | A*03:01 | 50 tests |
0 (Contact us) |
|
| ALLAVGATK | ４°C | |||||
|
|
TC-0103-2 |
HLA-A*03:01 Influenza NP Tetramer-ILRGSVAHK-APC |
|
|||
|
|
virus | APC | A*03:01 | 50 tests |
0 (Contact us) |
|
| ILRGSVAHK | ４°C | |||||
|
|
TC-0103-4 |
HLA-A*03:01 Influenza NP Tetramer-ILRGSVAHK-BV421 |
|
|||
|
|
virus | BV421 | A*03:01 | 50 tests |
0 (Contact us) |
|
| ILRGSVAHK | ４°C | |||||
|
|
TC-0137-4 |
HLA-A*03:01 HPV E6 Tetramer-KLCLRFLSK-BV421 |
|
|||
|
|
virus | BV421 | A*03:01 | 50 tests |
0 (Contact us) |
|
| KLCLRFLSK | 64-72 | ４°C | ||||
|
|
TC-0138-2 |
HLA-A*03:01 HIV nef Tetramer-QVPLRPMTYK-APC |
|
|||
|
|
virus | APC | A*03:01 | 50 tests |
0 (Contact us) |
|
| QVPLRPMTYK | 73-82 | ４°C | ||||
|
|
TC-0105-4 |
HLA-A*03:01 hTERT Tetramer-KLFGVLRLK-BV421 |
|
|||
|
|
cancer | BV421 | A*03:01 | 50 tests |
0 (Contact us) |
|
| KLFGVLRLK | ４°C | |||||
|
|
TC-0138-4 |
HLA-A*03:01 HIV nef Tetramer-QVPLRPMTYK-BV421 |
|
|||
|
|
virus | BV421 | A*03:01 | 50 tests |
0 (Contact us) |
|
| QVPLRPMTYK | 73-82 | ４°C | ||||
|
|
TC-0166-2 |
HLA-A*03:01 gp100 Tetramer-ALLAVGATK-APC |
|
|||
|
|
cancer | APC | A*03:01 | 50 tests |
0 (Contact us) |
|
| ALLAVGATK | ４°C | |||||
|
|
TC-0105-1 |
HLA-A*03:01 hTERT Tetramer-KLFGVLRLK-PE |
|
|||
|
|
cancer | PE | A*03:01 | 50 tests |
0 (Contact us) |
|
| KLFGVLRLK | ４°C | |||||
|
|
TS-M033-4 |
HLA-A*03:01 EBV EBNA3A 603-611 Tetramer-RLRAEAQVK-BV421 |
|
|||
|
|
virus | BV421 | A*03:01 | 50 tests |
0 (Contact us) |
|
| RLRAEAQVK | 603-611 | ４°C | ||||
|
|
TC-0166-4 |
HLA-A*03:01 gp100 Tetramer-ALLAVGATK-BV421 |
|
|||
|
|
cancer | BV421 | A*03:01 | 50 tests |
0 (Contact us) |
|
| ALLAVGATK | ４°C | |||||
|
|
TC-0109-1 |
HLA-A*03:01 HIV p17 gag Tetramer-RLRPGGKKK-PE |
|
|||
|
|
virus | PE | A*03:01 | 50 tests |
0 (Contact us) |
|
| RLRPGGKKK | ４°C | |||||
|
|
TC-0109-4 |
HLA-A*03:01 HIV p17 gag Tetramer-RLRPGGKKK-BV421 |
|
|||
|
|
virus | BV421 | A*03:01 | 50 tests |
0 (Contact us) |
|
| RLRPGGKKK | ４°C | |||||
|
|
TC-0138-1 |
HLA-A*03:01 HIV nef Tetramer-QVPLRPMTYK-PE |
|
|||
|
|
virus | PE | A*03:01 | 50 tests |
0 (Contact us) |
|
| QVPLRPMTYK | 73-82 | ４°C | ||||
|
|
TC-0108-2 |
HLA-A*03:01 Survivin 18-27 (modK) Tetramer-RISTFKNWPK-APC |
|
|||
|
|
cancer | APC | A*03:01 | 50 tests |
0 (Contact us) |
|
| RISTFKNWPK | ４°C | |||||
|
|
TC-0105-2 |
HLA-A*03:01 hTERT Tetramer-KLFGVLRLK-APC |
|
|||
|
|
cancer | APC | A*03:01 | 50 tests |
0 (Contact us) |
|
| KLFGVLRLK | ４°C | |||||
|
|
TS-M124-4 |
HLA-A*03:01 EBV BRLF1 Tetramer-RVRAYTYSK-BV421 |
|
|||
|
|
virus | BV421 | A*03:01 | 50 tests |
0 (Contact us) |
|
| RVRAYTYSK | ４°C | |||||
|
|
TC-8032-1 |
HLA-A*03:01 KRAS7-16 G12V Tetramer-VVVGAVGVGK-PE |
|
|||
|
|
cancer | PE | A*03:01 | 50 tests |
0 (Contact us) |
|
| VVVGAVGVGK | 7-16 | ４°C | ||||
|
|
TC-8031-2 |
HLA-A*03:01 KRAS7-16 G12D Tetramer-VVVGADGVGK-APC |
|
|||
|
|
cancer | APC | A*03:01 | 50 tests |
0 (Contact us) |
|
| VVVGADGVGK | 7-16 | ４°C | ||||
|
|
TC-8031-1 |
HLA-A*03:01 KRAS7-16 G12D Tetramer-VVVGADGVGK-PE |
|
|||
|
|
cancer | PE | A*03:01 | 50 tests |
0 (Contact us) |
|
| VVVGADGVGK | 7-16 | ４°C | ||||
|
|
TS-M255-2 |
HLA-A*03:01 ATR Neoepitope Tetramer-KLYEEPLLK-APC |
|
|||
|
|
cancer | APC | A*03:01 | 50 tests |
0 (Contact us) |
|
| KLYEEPLLK | ４°C | |||||
|
|
TS-M251-2 |
HLA-A*03:01 SIRT2 Neoepitope Tetramer-KIFSEVTLK-APC |
|
|||
|
|
cancer | APC | A*03:01 | 50 tests |
0 (Contact us) |
|
| KIFSEVTLK | ４°C | |||||
|
|
TC-8034-1 |
HLA-A*03:01 KRAS7-16 WT Tetramer-VVVGAGGVGK-PE |
|
|||
|
|
cancer | PE | A*03:01 | 50 tests |
0 (Contact us) |
|
| VVVGAGGVGK | 7-16 | ４°C | ||||
|
|
TC-8030-2 |
HLA-A*03:01 KRAS7-16 G12C Tetramer-VVVGACGVGK-APC |
|
|||
|
|
cancer | APC | A*03:01 | 50 tests |
0 (Contact us) |
|
| VVVGACGVGK | 7-16 | ４°C | ||||
|
|
TS-M252-1 |
HLA-A*03:01 PRPF6 Neoepitope Tetramer-KILDAVVAQK-PE |
|
|||
|
|
cancer | PE | A*03:01 | 50 tests |
0 (Contact us) |
|
| KILDAVVAQK | ４°C | |||||
|
|
TC-8033-1 |
HLA-A*03:01 KRAS8-16 WT Tetramer-VVGAGGVGK-PE |
|
|||
|
|
cancer | PE | A*03:01 | 50 tests |
0 (Contact us) |
|
| VVGAGGVGK | 8-16 | ４°C | ||||
|
|
TC-8030-1 |
HLA-A*03:01 KRAS7-16 G12C Tetramer-VVVGACGVGK-PE |
|
|||
|
|
cancer | PE | A*03:01 | 50 tests |
0 (Contact us) |
|
| VVVGACGVGK | 7-16 | ４°C | ||||
|
|
TS-M251-1 |
HLA-A*03:01 SIRT2 Neoepitope Tetramer-KIFSEVTLK-PE |
|
|||
|
|
cancer | PE | A*03:01 | 50 tests |
0 (Contact us) |
|
| KIFSEVTLK | ４°C | |||||
|
|
TC-8033-2 |
HLA-A*03:01 KRAS8-16 WT Tetramer-VVGAGGVGK-APC |
|
|||
|
|
cancer | APC | A*03:01 | 50 tests |
0 (Contact us) |
|
| VVGAGGVGK | 8-16 | ４°C | ||||
|
|
TC-8029-1 |
HLA-A*03:01 KRAS8-16 G12C Tetramer-VVGACGVGK-PE |
|
|||
|
|
cancer | PE | A*03:01 | 50 tests |
0 (Contact us) |
|
| VVGACGVGK | 8-16 | ４°C | ||||
|
|
TS-M252-2 |
HLA-A*03:01 PRPF6 Neoepitope Tetramer-KILDAVVAQK-APC |
|
|||
|
|
cancer | APC | A*03:01 | 50 tests |
0 (Contact us) |
|
| KILDAVVAQK | ４°C | |||||
|
|
TS-M255-1 |
HLA-A*03:01 ATR Neoepitope Tetramer-KLYEEPLLK-PE |
|
|||
|
|
cancer | PE | A*03:01 | 50 tests |
0 (Contact us) |
|
| KLYEEPLLK | ４°C | |||||
|
|
TS-M254-1 |
HLA-A*03:01 MYO1B Neoepitope Tetramer-KINKNPKYK-PE |
|
|||
|
|
cancer | PE | A*03:01 | 50 tests |
0 (Contact us) |
|
| KINKNPKYK | ４°C | |||||
|
|
TC-8034-2 |
HLA-A*03:01 KRAS7-16 WT Tetramer-VVVGAGGVGK-APC |
|
|||
|
|
cancer | APC | A*03:01 | 50 tests |
0 (Contact us) |
|
| VVVGAGGVGK | 7-16 | ４°C | ||||
|
|
TS-M254-2 |
HLA-A*03:01 MYO1B Neoepitope Tetramer-KINKNPKYK-APC |
|
|||
|
|
cancer | APC | A*03:01 | 50 tests |
0 (Contact us) |
|
| KINKNPKYK | ４°C | |||||
|
|
TC-8032-2 |
HLA-A*03:01 KRAS7-16 G12V Tetramer-VVVGAVGVGK-APC |
|
|||
|
|
cancer | APC | A*03:01 | 50 tests |
0 (Contact us) |
|
| VVVGAVGVGK | 7-16 | ４°C | ||||
|
|
TC-8029-2 |
HLA-A*03:01 KRAS8-16 G12C Tetramer-VVGACGVGK-APC |
|
|||
|
|
cancer | APC | A*03:01 | 50 tests |
0 (Contact us) |
|
| VVGACGVGK | 8-16 | ４°C | ||||
|
|
TS-M253-2 |
HLA-A*03:01 GPNMB Neoepitope Tetramer-TLDWLLQTPK-APC |
|
|||
|
|
cancer | APC | A*03:01 | 50 tests |
0 (Contact us) |
|
| TLDWLLQTPK | ４°C | |||||
|
|
TS-M253-1 |
HLA-A*03:01 GPNMB Neoepitope Tetramer-TLDWLLQTPK-PE |
|
|||
|
|
cancer | PE | A*03:01 | 50 tests |
0 (Contact us) |
|
| TLDWLLQTPK | ４°C | |||||
1
- The availability is based on the information in Japan at 17:00, Mar 12, 2026 in JST.
- The special price is shown in red color.
- Please note that products cannot be ordered from this website. To purchase the items listed in this website, please contact us or local distributers.
- For storage temparature: RT: room temparature
- Please note that products in this website might be changed or discontinued without notification in advance for quality improvement.